Authors:
Shusterman, S
Grupp, SA
Barr, R
Carpentieri, D
Zhao, HQ
Maris, JM
Citation: S. Shusterman et al., The angiogenesis inhibitor TNP-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease, CLIN CANC R, 7(4), 2001, pp. 977-984
Authors:
Stern, JW
Fang, JJ
Shusterman, S
Pierson, G
Barr, R
Pawel, B
Diller, L
Grupp, SA
Citation: Jw. Stern et al., Angiogenesis inhibitor TNP-470 during bone marrow transplant: Safety in a preclinical model, CLIN CANC R, 7(4), 2001, pp. 1026-1032
Authors:
Grupp, SA
Stern, JW
Bunin, N
Nancarrow, C
Ross, AA
Mogul, M
Adams, R
Grier, HE
Gorlin, JB
Shamberger, R
Marcus, K
Neuberg, D
Weinstein, HJ
Diller, L
Citation: Sa. Grupp et al., Tandem high-dose therapy in rapid sequence for children with high-risk neuroblastoma, J CL ONCOL, 18(13), 2000, pp. 2567-2575
Citation: S. Shusterman et al., Inhibition of tumor growth in a human neuroblastoma xenograft model with TNP-470, MED PED ONC, 35(6), 2000, pp. 673-676
Authors:
Donovan, J
Temel, J
Zuckerman, A
Gribben, J
Fang, JJ
Pierson, G
Ross, A
Diller, L
Grupp, SA
Citation: J. Donovan et al., CD34 selection as a stem cell purging strategy for neuroblastoma: Preclinical and clinical studies, MED PED ONC, 35(6), 2000, pp. 677-682